Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000911916-16-000687)

Filing Details

Accession Number:: 0000911916-16-000687
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-01 16:28:15
Reporting Period:: 2016-11-01

Filing Date:: 2016-11-01
Accepted Time:: 2016-11-01 16:28:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348649	Colucid Pharmaceuticals Inc.	CLCD	Pharmaceutical Preparations (2834)	203419541

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1639972	C. Linda Hogan	C/O Colucid Pharmaceuticals, Inc. 222 Third Street Cambridge MA 02142	Head, Bus. Dev. And Strategy	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-01	719	$6.75	719	No	4	M	Direct
Common Stock	Disposition	2016-11-01	719	$30.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2016-11-01	719	$0.00	719	$6.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,031		2026-03-04	No	4	M	Direct

Footnotes

Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016.
Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.